Why pay $1 when you can pay $2 or $12 for the same thing? Here’s a tour through history’s most entertaining price anomalies.

IBM Common Stock (IBM) stock saw a decline, ending the day at $222.78 which represents a decrease of $-2.11 or -0.94% from the prior close of $224.89. The stock opened at $223.14 and touched a low of ...

including shares of its common stock and common stock equivalents, for an aggregate offering price of $7.65 million to new and existing investors. 1,449,997 registered shares of common stock and ...

Deutsche Bank has recently reduced MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) stock to Hold rating, as announced on December 12, 2024, according to Finviz. Earlier, on October 22, 2024, Redburn ...

Coastal also granted the underwriters a 30-day option to purchase up to an additional 180,000 shares of its Common Stock sold in this offering at the public offering price, less underwriting ...

Despite near-term struggles, Boeing offers long-term upside, with potential 20% gains by 2027 if it successfully executes its ...

Quantum Computing (QUBT) announced that it has entered into securities purchase agreements with institutional investors for the purchase and ...

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious ...

ImmunityBio shares lost a third of their value Wednesday after the company shared pricing for its public offering. Shares fell 32.2% to $3.15 in recent trading. The stock had fallen about 43.8% over ...

In connection with the offering, Myomo has granted the underwriter a 30-day option to purchase up to 450,000 additional shares of its common stock at the public offering price, less the ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offerin ...